NABsys Secures $7,000,000 Series B Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1c9778c3-c77e-42a3-995e-b617f7c6b946&Preview=1 -
Date
2/17/2010 -
Company Name
NABsys -
Mailing Address
349 Eddy St Providence, RI 02903 -
Company Description
NABsys aims to make whole-genome DNA sequencing fast, inexpensive, and accurate enough to be used in clinical care. Our approach builds on existing solid-state technologies to create a whole-genome sequencing technology that employs electronic detection, does not depend on a polymerase, and directly obtains DNA sequence information over hundreds of thousands of bases. -
Website
http://www.nabsys.com -
Transaction Type
Venture Equity -
Transaction Amount
$7,000,000 -
Transaction Round
Series B -
Proceeds Purposes
The funding will be used to accelerate the development and commercialization of the company’s proprietary DNA sequencing platform, which leverages semiconductor technology to achieve the scope and scale required for full integration of genomics into medicine. -
M&A Terms
-
Venture Investor
Stata Venture Partners -
Venture Investor
Undisclosed
